🇺🇸 Clobex Spray in United States
23 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 23
Most-reported reactions
- Psoriasis — 6 reports (26.09%)
- Drug Ineffective — 4 reports (17.39%)
- Cough — 2 reports (8.7%)
- Fatigue — 2 reports (8.7%)
- Injection Site Erythema — 2 reports (8.7%)
- Pain In Extremity — 2 reports (8.7%)
- Pruritus — 2 reports (8.7%)
- Acute Tonsillitis — 1 report (4.35%)
- Arthropathy — 1 report (4.35%)
- Asthenia — 1 report (4.35%)
Other Dermatology approved in United States
Frequently asked questions
Is Clobex Spray approved in United States?
Clobex Spray does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Clobex Spray in United States?
Galderma R&D is the originator. The local marketing authorisation holder may differ — check the official source linked above.